Robert Illingworth

Biography

Background

  • 2019 – present. Group Leader. MRC Centre for Regenerative Medicine, University of Edinburgh.
  • 2018–2019. Simons Initiative for the Developing Brain (SIDB) Transition to independence post. The University of Edinburgh.
  • 2010–2018. Postdoc with Prof. Wendy Bickmore. MRC Human Genetics Unit. Epigenetics of mammalian embryonic development.
  • 2008-2010. Postdoc with Sir Adrian Bird. Wellcome Trust Centre for Cell Biology, The University of Edinburgh. DNA methylation screening in primary Human brain tissue.
  • 2004-2008. PhD student with Sir Adrian Bird. Wellcome Trust Centre for Cell Biology, The University of Edinburgh. Developing novel biochemical approaches for the characterisation of mammalian CpG island methylation.
  • 1999-2003. BSc in Molecular Biology. The University of Edinburgh.

Research summary

Epigenetics and Brain Development

Mammalian embryonic development is the process whereby a single naïve cell is expanded, and serially specialised, to produce all of the functional cell types of the adult body. This intricate process is governed by proteins, which bind to regulatory DNA sequences and establish the appropriate gene expression over time and in the correct locations. One such family of protein effectors called polycomb repressive complexes (PRCs), function to block gene expression by chemically and physically modifying chromatin - the packaged form of DNA. 

The aim of my research is to understand how these epigenetic regulators control gene expression during early brain development. In particular I am interested in how histone-modifying enzymes control the balance between self-renewal and differentiation to ensure appropriate brain growth. Understanding this balance is key to interpreting the molecular differences seen in a broad-range of neurodevelopmental disorders (NDDs). 

Aims and areas of interest

Building a brain, the most compositionally and functionally complex human organ, requires the tightly coordinated expansion, specialization and migration of neural cell types. Transcription factors govern this process, however the spatial and temporal fidelity which is essential for brain function relies heavily on epigenetic modifiers. By altering the chemical and structural properties of chromatin, epigenetic systems ensure the proportionate transcriptional response to developmental cues. Accordingly, causal mutations in epigenetic regulators are prominent in both congenital and acquired brain disorders. Often the phenotypes and underlying genetic lesions of NDDs are known, yet the precise molecular aetiology is not. This is due to our limited understanding of how epigenetic systems drive gene expression programmes during normal brain development.

We combine cutting edge molecular techniques in combination with mouse and cell based model systems to understand the role played by epigenetic modifiers during brain development, and how their mutation contributes to disease.

Specific Aims:

  1. How are epigenetic modifiers targeted to chromatin in the developing brain?
  2. How do neural-specific protein components adapt the functionality of epigenetic modifiers?
  3. What is the relative contribution of histone modification activity for gene regulation in the neural lineage?
  4. Why do mutations in functionally opposing epigenetic regulators lead to equivalent disordered brain phenotypes?

View all 19 publications on Research Explorer

This article was published on